CHICAGO, June 13, 2017 — The Seventh International Conference of the Novalis Circle brought together a selective group of two hundred international experts in neurosurgery, radiation oncology and medical physics to share the latest best practices and discuss clinical synergies of precision radiosurgery and surgery. An international faculty of 35 speakers covered clinical and technological advancements, focusing on stereotactic radiosurgery of secondary metastasis in the brain and spine, intra-cranial primary tumors, arteriovenous malformations and functional disorders.
A key focus of the meeting was placed on improving outcomes for patients with intra-cranial metastasis. “Due to wider adoption of stereotactic radiosurgery, intra-cranial disease is no longer the main limitation in cancer survival, and there is a clear shift in clinical management towards providing longer-term quality of life,” said Dr. Douglas Kondziolka, MD from NYU Langone Medical Center. Success of focal therapies is better quantified by employing response assessment techniques that unlock the understanding of tumor biology and personalize patient treatments. “All tumors are different and new imaging breakthroughs allow us to distinguish sooner than ever the ones that respond from those that don’t, enabling us to adjust therapy as needed”. As such practices begin to have a wider adoption, the expert community has also embraced a cohesive practice of collecting and reporting clinical outcomes under the auspice of a national stereotactic radiosurgery (SRS) registry. Sanctioned by the American Academy of Neurological Surgeons (AANS) and the American Society for Radiation Oncology (ASTRO) to establish the new benchmark in treatment quality parameters, the United States SRS Registry provides an effective alternative to lengthy and costly prospective randomized trials.
The main strength of the Novalis Circle community relies on integrating surgical expertise into radiation oncology practices. Multi-disciplinary care is the key to successful improvements for tumor patients as preservation surgery coupled with stereotactic radiosurgery is a more ideal method for disease treatment with uncompromised functional preservation. The role of technology in blending the two practices lays the foundation for new techniques such as adaptive hybrid surgery in patients with either intra-cranial benign disease or spinal malignancies.
“Novalis Radiosurgery is celebrating 20 years of innovation this year,” said Stefan Vilsmeier, President and CEO, Brainlab. “Indication-specific treatments and multidisciplinary team approaches have become the major game changer in the last five years and have proven to increase quality of life and overall treatment success for patients. The Novalis Circle community continues to be the key driver for growing the adoption and effectiveness of stereotactic radiosurgery practices.”
The Institute for Medical Education accredited the Seventh International Conference of the Novalis Circle offering continuing medical education (CME) credits for participants through a dynamic, active, participatory environment with opportunities to learn and apply new skills.
In addition to the annual international conferences, the Novalis Circle also hosts smaller educational symposia worldwide throughout the year to continue cross-disciplinary education.
The Novalis Circle is a worldwide network of clinicians dedicated to the advancement of radiosurgery. It provides a communication and collaboration network for developing new ideas and optimizing treatments that will continue to change the face of cancer treatment. Learn more at novaliscircle.org.
Brainlab, headquartered in Munich, develops, manufactures and markets software-driven medical technology, enabling access to advanced, less invasive patient treatments.
Core products center on information-guided surgery, radiosurgery, precision radiation therapy, digital operating room integration, and information and knowledge exchange. Brainlab technology powers treatments in radiosurgery and radiotherapy as well as numerous surgical fields including neurosurgery, orthopedic, ENT, CMF, spine and trauma.
Privately held since its formation in Munich, Germany in 1989, Brainlab has more than 11,800 systems installed in over 100 countries. Brainlab employs 1,370 people in 18 offices worldwide, including 450 Research & Development engineers, who form a crucial part of the product development team. To learn more, visit brainlab.com.